Scientists from the National Institutes for Food and Drug Control have characterized antibody-drug conjugates (ADCs) using ...

The artificial intelligence community is raving over a new reasoning model that has surprised even Silicon Valley.

Celltrion targets innovative drug development with new ADC and antibody candidates Celltrion aims for growth by venturing ...

Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five ...

Pancreatic cancer is one of the deadliest of all cancers. Only 12 per cent of men diagnosed with pancreatic cancer are alive five years after diagnosis; for women it is 14 per cent.

The Phase I ADC trial will evaluate the safety and efficacy of the company’s drug which targets tumours whilst leaving normal ...

New CEO James Park Delivers First Presentation at J.P. Morgan Healthcare Conference on 'Advancing as a Global CDMO Leader' ...

The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...

Lotte Biologics CEO James Park aims to secure ADC orders at U.S. plant this year Lotte Biologics new leadership seeks to ...

Korea’s top biopharmaceutical firms, Celltrion and Samsung Biologics, envisioned their future strategies for expansion at J.P ...

IMAC Holdings, Inc. (Nasdaq: BACK) ("IMAC Holdings" or the "Company") has launched Ignite Proteomics LLC ("Ignite"), its new subsidiary dedicated to helping ...

Proteins drive cell behavior and are the direct targets of many new cancer drugs, especially antibody-drug conjugates (ADCs) ...